AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
16.03
-0.47 (-2.85%)
At close: Mar 28, 2024, 4:00 PM
15.46
-0.57 (-3.56%)
After-hours: Mar 28, 2024, 5:37 PM EDT

AVITA Medical Cash Flow Statement

Millions AUD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
-35.38-26.67-25.14-42.03-25.1-12.74-8.17-5.52
Depreciation & Amortization
1.381.260.660.970.270.1100
Share-Based Compensation
8.3873.5916.591.951.4600
Other Operating Activities
-12.39-0.6815.41.723.64-1.792.1-0.11
Operating Cash Flow
-38.01-19.09-5.5-22.75-19.25-12.96-6.08-5.64
Capital Expenditures
-1.38-0.45-0.07-0.59-1.02-0.37-0.31-0.03
Change in Investments
3.05-18.81-49.550000.450
Other Investing Activities
-0.07-0.07-0.07-0.26-0.21---
Investing Cash Flow
1.61-19.33-49.68-0.85-1.23-0.370.14-0.03
Share Issuance / Repurchase
1.610.90.0182.1832.7122.796.427.12
Debt Issued / Paid
38.7600-0.04-0.06-0.0600
Other Financing Activities
----5.08-2.93-1.44-0.58-0.47
Financing Cash Flow
40.370.90.0177.0629.7121.35.856.65
Exchange Rate Effect
-0.02-0.03-0.0600.160.100
Net Cash Flow
3.95-37.55-55.2453.479.398.07-0.090.98
Free Cash Flow
-39.39-19.54-5.57-23.34-20.27-13.33-6.38-5.67
Free Cash Flow Margin
-76.38%-51.92%-16.08%-128.30%-177.89%-153.82%-124.33%-313.87%
Free Cash Flow Per Share
-1.55-0.78-0.22-1.15-1.26-1.43--
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).